Larimar Therapeutics News

Larimar Therapeutics | 8-K: Current report

Jun 10 06:08 ET

Larimar Therapeutics | 8-K: Current report

May 31 16:19 ET

Larimar Therapeutics | 8-K: Current report

May 30 16:15 ET

Larimar Therapeutics | 8-K: Current report

May 20 16:12 ET

Larimar Therapeutics | S-3: Registration statement for specified transactions by certain issuers

May 9 16:56 ET

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results

May 9 07:07 ET

Larimar Therapeutics | DEF 14A: Definitive information statements

Apr 29 16:09 ET

Larimar Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 06:12 ET

Larimar Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14 17:11 ET

Larimar Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 14 17:10 ET

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Fourth Quarter and Full Year 2023 Operating and Financial Results and Provides Update on Nomlabofusp Development

Mar 14 16:10 ET

Larimar Therapeutics | 8-K: Current report

Mar 11 16:13 ET

Larimar Therapeutics | 8-K: Current report

Feb 16 16:10 ET

Larimar Therapeutics | 8-K: Current report

Feb 14 06:12 ET

Larimar Therapeutics | 8-K: Current report

Feb 12 07:09 ET

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Third Quarter 2023 Operating and Financial Results

Nov 14, 2023 07:14 ET

Larimar Therapeutics | 8-K: Current report

Oct 3, 2023 16:31 ET

Larimar Therapeutics | 8-K: Current report

Aug 14, 2023 08:00 ET

Larimar Therapeutics | 8-K: Larimar Therapeutics Reports Second Quarter 2023 Operating and Financial Results

Aug 10, 2023 07:03 ET

Larimar Therapeutics | 8-K: Current report

Jul 25, 2023 07:02 ET